Emergent BioSolutions Inc.
EBS | NYSE
$6.55
-$0.25 (-3.68%)
At close: Sep 21, 2026, 4:00 PM ET
$6.55
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:18 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 12.61 | -2.66 | -0.16 | -2.80 | 10.60 | 15.47 |
PEG Ratio | -0.10 | 0.04 | 0 | 0.01 | -0.36 | 0.03 |
PS Ratio | 0.89 | 0.49 | 0.12 | 0.53 | 1.31 | 2.99 |
PB Ratio | 1.27 | 1.05 | 0.19 | 0.43 | 1.44 | 3.26 |
P/FCF Ratio | 4.22 | 14.15 | -0.48 | -3.95 | 24.20 | 11.95 |
P/OCF Ratio | 3.88 | 8.63 | -0.60 | -17.35 | 7.24 | 8.79 |
OCF/S Ratio | 22.96 | 5.62 | -19.66 | -3.05 | 18.10 | 34.04 |
Debt / Equity Ratio | 1.09 | 1.40 | 1.32 | 1.03 | 0.54 | 0.64 |
Quick Ratio | 2.41 | 1.77 | 0.54 | 0.70 | 2.47 | 2.31 |
Current Ratio | 5.01 | 3.69 | 1.04 | 0.98 | 3.40 | 3.11 |
Asset Turnover | 0.56 | 0.75 | 0.58 | 0.35 | 0.60 | 0.55 |
Interest Coverage | 1.86 | -1.53 | -8.26 | -4.56 | 9.90 | 14.01 |
Return on Equity | 10.07% | -39.48% | -117.13% | -15.25% | 13.62% | 21.13% |
Return on Assets | 3.99% | -13.72% | -41.71% | -6.68% | 7.42% | 10.61% |
Return on Invested Capital | 5.90% | -8.84% | -45.81% | -5.66% | 9.43% | 12.80% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 47.19% | 35.97% | 34.31% | 42.33% | 44.72% | 54.72% |
Net Profit Margin | 7.08% | -18.26% | -72.48% | -18.94% | 12.38% | 19.39% |
Pretax Profit Margin | 11.15% | -13.69% | -69.68% | -19.60% | 17.10% | 26.11% |
Operating Profit Margin | 14.83% | -10.42% | -69.23% | -15.21% | 19.25% | 27.80% |
FCF Margin | 21.11% | 3.43% | -24.58% | -13.41% | 5.42% | 25.04% |
EBITDA Margin | 32.36% | 5.12% | -4.48% | 1.40% | 28.43% | 38.62% |
Add to Watchlist
Select watchlists to add or remove EBS